(Q71015274)
Statements
The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia (English)
A L Hillman
J S Schwartz
M K Willian
E Peskin
C G Roehrborn
J E Oesterling
M F Mason
C J Maurath
P A Deverka
1 February 1996